LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 765 | 526 | 3143 | 0.1673 | -0.1679 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 765 | 501 | 3095 | 0.1618 | -0.1894 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 765 | 507 | 3066 | 0.1654 | -0.1857 |
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 765 | 454 | 3140 | 0.1446 | -0.2260 |
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 765 | 544 | 3151 | 0.1726 | -0.1538 |
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 765 | 506 | 3152 | 0.1605 | -0.1832 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 765 | 398 | 3143 | 0.1266 | -0.2742 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 765 | 389 | 3095 | 0.1257 | -0.2849 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 765 | 463 | 3066 | 0.1510 | -0.2218 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 765 | 418 | 3140 | 0.1331 | -0.2567 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 765 | 558 | 3151 | 0.1771 | -0.1432 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 765 | 470 | 3152 | 0.1491 | -0.2122 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 765 | 269 | 3143 | 0.0856 | -0.4011 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 765 | 343 | 3095 | 0.1108 | -0.3282 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 765 | 450 | 3066 | 0.1468 | -0.2328 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 765 | 462 | 3140 | 0.1471 | -0.2193 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 765 | 490 | 3151 | 0.1555 | -0.1960 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 765 | 489 | 3152 | 0.1551 | -0.1968 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 765 | 821 | 3140 | 0.2614 | 0.0353 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 765 | 829 | 3151 | 0.2630 | 0.0401 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 765 | 873 | 3152 | 0.2769 | 0.0667 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 765 | 705 | 3140 | 0.2245 | -0.0393 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 765 | 721 | 3151 | 0.2288 | -0.0286 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 765 | 727 | 3152 | 0.2306 | -0.0247 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 765 | 762 | 3140 | 0.2427 | -0.0020 |